Literature DB >> 22349532

[Preeclampsia and HELLP syndrome as an obstetric emergency].

A-C Tallarek1, H Stepan.   

Abstract

Preeclampsia and HELLP syndrome are multisystemic hypertensive disorders in pregnancy. A causative treatment is not yet available. The obstetrician has to choose between the risk of prolongation of pregnancy for mother and fetus on the one hand and the hazard of prematurity on the other, when iatrogenic delivery is considered. As the clinical severity and progression of both diseases is very difficult to predict, an emergency situation can develop rapidly and unexpectedly. In this scenario a good interdisciplinary cooperation between obstetricians and intensive care physicians ensures an optimal outcome for the pregnant woman. This article gives an insight into both diseases and the clinical management.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349532     DOI: 10.1007/s00063-011-0038-1

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  12 in total

Review 1.  Management of mild chronic hypertension during pregnancy: a review.

Authors:  R L Ferrer; B M Sibai; C D Mulrow; E Chiquette; K R Stevens; J Cornell
Journal:  Obstet Gynecol       Date:  2000-11       Impact factor: 7.661

2.  Intensive care utilization during hospital admission for delivery: prevalence, risk factors, and outcomes in a statewide population.

Authors:  S Panchal; A M Arria; A P Harris
Journal:  Anesthesiology       Date:  2000-06       Impact factor: 7.892

3.  [Postpartum eclampsia and fulminant HELLP syndrome].

Authors:  M Schott; A Henkelmann; Y Meinköhn; J-P Jantzen
Journal:  Anaesthesist       Date:  2011-04-17       Impact factor: 1.041

Review 4.  Angiogenic factors and preeclampsia.

Authors:  May Lee Tjoa; Richard J Levine; S Ananth Karumanchi
Journal:  Front Biosci       Date:  2007-01-01

5.  Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy.

Authors:  M E Helewa; R F Burrows; J Smith; K Williams; P Brain; S W Rabkin
Journal:  CMAJ       Date:  1997-09-15       Impact factor: 8.262

Review 6.  Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy.

Authors:  Douglas M Woudstra; Sue Chandra; G Justus Hofmeyr; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

7.  The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome.

Authors:  Brett Young; Richard J Levine; Saira Salahuddin; Cong Qian; Kee-Hak Lim; S Ananth Karumanchi; Sarosh Rana
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05

8.  An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.

Authors:  Stefan Verlohren; Alberto Galindo; Dietmar Schlembach; Harald Zeisler; Ignacio Herraiz; Manfred G Moertl; Juliane Pape; Joachim W Dudenhausen; Barbara Denk; Holger Stepan
Journal:  Am J Obstet Gynecol       Date:  2009-10-21       Impact factor: 8.661

Review 9.  Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count.

Authors:  Baha M Sibai
Journal:  Obstet Gynecol       Date:  2004-05       Impact factor: 7.661

Review 10.  Magnesium sulphate versus phenytoin for eclampsia.

Authors:  L Duley; D Henderson-Smart
Journal:  Cochrane Database Syst Rev       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.